Natural history and prognosis of pediatric PSC with updates on management.
作者信息
Fuchs Yonathan, Valentino Pamela L
机构信息
Section of Gastroenterology and Hepatology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Section of Gastroenterology and Hepatology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
出版信息
Clin Liver Dis (Hoboken). 2023 Jan 13;21(2):47-51. doi: 10.1097/CLD.0000000000000006. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Natural history and prognosis of pediatric PSC with updates on management.儿童原发性硬化性胆管炎的自然病史与预后及管理进展
Clin Liver Dis (Hoboken). 2023 Jan 13;21(2):47-51. doi: 10.1097/CLD.0000000000000006. eCollection 2023 Feb.
2
Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis.儿童原发性硬化性胆管炎的临床病程和预后。
United European Gastroenterol J. 2016 Aug;4(4):562-9. doi: 10.1177/2050640615616012. Epub 2015 Oct 30.
3
Primary sclerosing cholangitis in children versus adults: lessons for the clinic.儿童原发性硬化性胆管炎与成人：对临床的启示。
Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):1025-1032. doi: 10.1080/17474124.2018.1521719. Epub 2018 Oct 1.
4
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.原发性硬化性胆管炎 781 例儿童自然史：多中心国际协作研究。
Hepatology. 2017 Aug;66(2):518-527. doi: 10.1002/hep.29204. Epub 2017 Jun 26.
5
Recent Insights into Pediatric Primary Sclerosing Cholangitis.小儿原发性硬化性胆管炎的最新研究进展。
Clin Liver Dis. 2022 Aug;26(3):489-519. doi: 10.1016/j.cld.2022.03.009. Epub 2022 Jun 25.
6
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.炎症性肠病合并原发性硬化性胆管炎患者的特征
J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 5.
7
Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc.儿童“PSC-IBD”：对患有原发性硬化性胆管炎的儿科患者中相关炎症性肠病的描述性报告
J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):296-300. doi: 10.1097/00005176-200109000-00013.
8
The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.儿童原发性硬化性胆管炎的自然病史：一项大型单中心纵向队列研究。
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):603-609. doi: 10.1097/MPG.0000000000001368.
9
Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.原发性硬化性胆管炎、自身免疫性肝炎和重叠在犹他州儿童中的表现：流行病学和自然病史。
Hepatology. 2013 Oct;58(4):1392-400. doi: 10.1002/hep.26454. Epub 2013 Aug 13.
10
Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.儿童原发性硬化性胆管炎的独特炎症性肠病表型：一项单中心研究
J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):404-409. doi: 10.1097/MPG.0000000000001531.
引用本文的文献
1
Good long-term outcomes of primary sclerosing cholangitis in childhood.儿童原发性硬化性胆管炎的良好长期预后。
JHEP Rep. 2024 May 25;6(8):101123. doi: 10.1016/j.jhepr.2024.101123. eCollection 2024 Aug.
本文引用的文献
1
Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.原发性硬化性胆管炎的 MRI 和 MR 胆胰管成像报告标准：国际原发性硬化性胆管炎研究组磁共振工作组指南。
Eur Radiol. 2022 Feb;32(2):923-937. doi: 10.1007/s00330-021-08147-7. Epub 2021 Aug 6.
2
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study.儿童肝移植后原发性硬化性胆管炎复发：一项国际观察性研究。
Hepatology. 2021 Oct;74(4):2047-2057. doi: 10.1002/hep.31911. Epub 2021 Sep 9.
3
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.口服万古霉素、熊去氧胆酸或无治疗用于小儿原发性硬化性胆管炎：一项匹配分析。
Hepatology. 2021 Mar;73(3):1061-1073. doi: 10.1002/hep.31560.
4
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.小儿硬化性胆管炎结局（SCOPE）指数：儿童预后工具。
Hepatology. 2021 Mar;73(3):1074-1087. doi: 10.1002/hep.31393. Epub 2020 Dec 19.
5
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.磁共振成像和振动控制瞬时弹性成像在原发性硬化性胆管炎风险分层中的互补价值。
Am J Gastroenterol. 2019 Dec;114(12):1878-1885. doi: 10.14309/ajg.0000000000000461.
6
A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis.熊去氧胆酸在儿童原发性硬化性胆管炎中撤药与重新用药的前瞻性试验
Hepatol Commun. 2019 Aug 29;3(11):1482-1495. doi: 10.1002/hep4.1421. eCollection 2019 Nov.
7
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment.儿童炎症性肠病相关原发性硬化性胆管炎与更轻微的临床活动相关，但更频繁的亚临床炎症和生长障碍。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1509-1517.e7. doi: 10.1016/j.cgh.2019.08.048. Epub 2019 Sep 4.
8
Size mismatch in deceased donor liver transplantation and its impact on graft survival.供体肝移植中大小不匹配及其对移植物存活的影响。
Clin Transplant. 2019 Aug;33(8):e13662. doi: 10.1111/ctr.13662. Epub 2019 Jul 26.
9
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.γ-谷氨酰转移酶降低与儿童原发性硬化性胆管炎的良好预后相关。
Hepatol Commun. 2018 Sep 25;2(11):1369-1378. doi: 10.1002/hep4.1251. eCollection 2018 Nov.
10
Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group.PSC-A 磁共振成像使用建议——国际 PSC 研究组立场声明
Hepatology. 2017 Nov;66(5):1675-1688. doi: 10.1002/hep.29293. Epub 2017 Sep 29.
Zotero 插件